Published in Arthritis Rheum on February 01, 1967
Cellular immunity to nuclear antigens in systemic lupus erythematosus. J Clin Invest (1972) 0.98
Selective depression of the xenogeneic cell-mediated lympholysis in systemic lupus erythematosus. J Clin Invest (1979) 0.95
Cell-mediated immunity in systemic lupus erythematosus. Clin Exp Immunol (1977) 0.91
Cellular-versus-humoral autoimmune responses to salivary gland in Sjögren's syndrome. Clin Exp Immunol (1973) 0.87
Spontaneous delayed hypersensitivity to DNA in NZB mice. Immunology (1974) 0.86
Tissue antibodies in idiopathic autoimmune haemolytic anaemia. Clin Exp Immunol (1971) 0.79
Peripheral blood lymphocyte response to phytomitogens in systemic lupus erythematosus. Ann Rheum Dis (1975) 0.78
Cellular immunity in systemic lupus erythematosus as evidenced in vitro by leucocyte migration inhibition tests. Ann Rheum Dis (1977) 0.75
The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum (1982) 67.54
Molecular cloning of cDNA for CENP-B, the major human centromere autoantigen. J Cell Biol (1987) 4.50
CENP-C, an autoantigen in scleroderma, is a component of the human inner kinetochore plate. Cell (1992) 3.70
Range of antinuclear antibodies in "healthy" individuals. Arthritis Rheum (1997) 3.29
High titers of autoantibodies to topoisomerase I (Scl-70) in sera from scleroderma patients. Science (1986) 2.50
Injection of anticentromere antibodies in interphase disrupts events required for chromosome movement at mitosis. J Cell Biol (1990) 2.46
Reiter's syndrome associated with champylobacter fetus infection. Ann Intern Med (1977) 2.46
In vivo and in vitro chromosomal damage induced by LSD-25. N Engl J Med (1967) 2.39
cDNA cloning of human DNA topoisomerase I: catalytic activity of a 67.7-kDa carboxyl-terminal fragment. Proc Natl Acad Sci U S A (1988) 2.38
Deletion of short arms of chromosome 4-5 in a child with defects of midline fusion. Humangenetik (1965) 2.37
Serum antinuclear antibodies in progressive systemic sclerosis (scleroderma). Arthritis Rheum (1968) 2.30
The clinical course of the proliferative and membranous forms of lupus nephritis. Ann Intern Med (1970) 2.29
Clinical associations of anticentromere antibodies and antibodies to topoisomerase I. A study of 355 patients. Arthritis Rheum (1988) 2.06
Molecular cloning of a human homologue of Drosophila heterochromatin protein HP1 using anti-centromere autoantibodies with anti-chromo specificity. J Cell Sci (1993) 1.90
Immunoglobulin class and pattern of nuclear fluorescence in systemic lupus erythematosus. N Engl J Med (1966) 1.90
Disruption of centromere assembly during interphase inhibits kinetochore morphogenesis and function in mitosis. Cell (1991) 1.85
A critical evaluation of enzyme immunoassays for detection of antinuclear autoantibodies of defined specificities. I. Precision, sensitivity, and specificity. Arthritis Rheum (1999) 1.85
The relation of immunoglobulin class, pattern of anti-nuclear antibody, and complement-fixing antibodies to DNA in sera from patients with systemic lupus erythematosus. J Clin Invest (1967) 1.82
The response of lymphocytes from non-immunized humans to antigen-antibody complexes. Clin Exp Immunol (1968) 1.79
A transcript map of the newly defined 165 kb Wolf-Hirschhorn syndrome critical region. Hum Mol Genet (1997) 1.71
Fanconi's anemia. Inherited susceptibility to chromosome breakage in various tissues. Ann Intern Med (1966) 1.67
Paternal trisomy 21 mosaicism and Down's syndrome. Am J Hum Genet (1971) 1.65
Alternative DNA replication patterns associated with long arm length of chromosomes 4 and 5 in the cri du chat syndrome. Cytogenetics (1966) 1.62
Raised antibody titres to E.B. virus in systemic lupus erythematosus. Lancet (1971) 1.60
Studies on lysosomes. XII. Redistribution of acid hydrolases in human lymphocytes stimulated by phytohemagglutinin. J Cell Biol (1968) 1.58
Criminality in XYY and XXY men. Science (1976) 1.57
Trisomy 22: a clinical entity. J Pediatr (1971) 1.55
Aseptic necrosis of bone in systemic lupus erythematosus. Relationship to corticosteroid therapy. Arch Intern Med (1978) 1.55
Stability of HL-A and appearance of other antigens (LIVA) at the surface of lymphoblasts grown in vitro. Haematologica (1969) 1.53
Role of the centromere/kinetochore in cell cycle control. Cold Spring Harb Symp Quant Biol (1991) 1.52
The syndrome of ectrodactyly, ectodermal dysplasia and cleft lip and palate: report of a family demonstrating a dominant inheritance pattern. Clin Genet (1972) 1.42
Serologic tests in rheumatic diseases. Postgrad Med (1969) 1.38
Prostaglandin E treatment of NZB/NZW mice. Arthritis Rheum (1977) 1.38
Multipurpose arthritis centers. A ten-year progress report. Arthritis Rheum (1988) 1.38
Location of the genes for human heavy chain immunoglobulin to chromosome 6. Proc Natl Acad Sci U S A (1978) 1.35
Appearance of hydrolase rich granules in human lymphocytes induced by phytohemagglutinin and antigens. Blood (1967) 1.35
Familial translocation with partial trisomy of 13 and 22: evidence that specific regions of chromosomes 13 and 22 are responsible for the phenotype of each trisomy. J Med Genet (1977) 1.30
Trisomy 21 mosaicism in a woman with two children with trisomy 21 Down's syndrome. J Med Genet (1974) 1.29
Prostaglandin E1 treatment of NZB/NZW F1 hybrid mice. II. Prevention of glomerulonephritis. Arthritis Rheum (1977) 1.29
Vinyl chloride exposure and human chromosome aberrations. Mutat Res (1975) 1.28
Confirmation of the regional localization of the genes for human acid alpha-glucosidase (GAA) and adenosine deaminase (ADA) by somatic cell hybridization. Ann Hum Genet (1984) 1.28
Precise identification of various chromosomal abnormalities. Ann Hum Genet (1973) 1.27
Chromosomal localization of human haemoglobin structural genes. Nature (1972) 1.26
Preferential development by mice of delayed hypersensitivity to purified basic proteins. J Allergy (1968) 1.26
Stimulation of human tonsillar lymphocytes in vitro. Clin Exp Immunol (1966) 1.23
64Cu metabolism in Menkes and normal cultured skin fibroblasts. Pediatr Res (1978) 1.21
Analysis of anticentromere autoantibodies using cloned autoantigen CENP-B. Proc Natl Acad Sci U S A (1987) 1.20
Characterization of the molecular defect in infantile and adult acid alpha-glucosidase deficiency fibroblasts. J Clin Invest (1978) 1.19
Clinical and laboratory aspects of raised virus antibody titres in systemic lupus erythematosus. Ann Rheum Dis (1973) 1.19
Neonatal hepatitis and biliary atresia associated with trisomy 17-18 syndrome. N Engl J Med (1969) 1.17
Immunoglobulin M autoantibody to vimentin intermediate filaments. J Clin Invest (1982) 1.16
L-asparaginase and blastogenesis. Lancet (1969) 1.16
Partial thyroxine-binding globulin deficiency in a family. Pediatrics (1969) 1.15
The production of immunoglobulins by human peripheral blood lymphocytes in vitro. Clin Exp Immunol (1967) 1.14
Arylsulfatase B deficiency in Maroteaux-Lamy syndrome: Cellular studies and carrier identification. Pediatr Res (1975) 1.13
Letter: Genetic heterogeneity in fucosidosis. Lancet (1973) 1.13
Leukemia in Fanconi's anemia: cytogenetic and tumor virus susceptibility studies. Blood (1970) 1.12
Double Beta-Lipoprotein: A New Genetic Variant in Man. Science (1965) 1.12
Paternal uniparental disomy for chromosome 14: a case report and review. Am J Med Genet (1997) 1.10
Products of lymphoid cells in continuous culture. Am J Pathol (1970) 1.10
A partial long arm deletion of chromosome 7:46,XY,del(7)(q32). J Med Genet (1977) 1.09
Familial de Lange syndrome. Report of three cases in a sibship. Clin Genet (1971) 1.09
Isozymes of human alpha-L-fucosidase detectable by starch gel electrophoresis. Clin Chim Acta (1974) 1.09
Proposed guidelines for diagnosis of chromosome mosaicism in amniocytes based on data derived from chromosome mosaicism and pseudomosaicism studies. Prenat Diagn (1992) 1.09
Polymorphism of human alpha fucosidase. Am J Hum Genet (1975) 1.09
Familial x/x translocation: t(x;x)(p22;q13) Cytogenet Cell Genet (1974) 1.08
Trisomy 12 mosaicism detected by mid-trimester amniocentesis. Prenat Diagn (1990) 1.07
Studies on ciliary dyskinesia factor in cystic fibrosis. IV. Its possible identification as anaphylatoxin (C3a)-IgG complex. Life Sci (1974) 1.07
Studies on ciliary dyskinesia factor in cystic fibrosis. I. Bioassay and heterozygote detection in serum. Pediatr Res (1973) 1.06
XXXXY boy. A 15-month-old child with normal intellectual development. Am J Dis Child (1970) 1.06
Patient care, resident stress, and government regulation. Am J Dis Child (1989) 1.06
Oral iloprost treatment in patients with Raynaud's phenomenon secondary to systemic sclerosis: a multicenter, placebo-controlled, double-blind study. Arthritis Rheum (1998) 1.05
Divergent racial trends in mortality from systemic lupus erythematosus. J Rheumatol (1995) 1.05
Prognostic significance of anticentromere antibodies and anti-topoisomerase I antibodies in Raynaud's disease. A prospective study. Arthritis Rheum (1991) 1.05
Molecular cytogenetic analysis of uterine leiomyoma and leiomyosarcoma by comparative genomic hybridization. Cancer Genet Cytogenet (2000) 1.04
In situ hybridization of chromosome loci. Fed Proc (1975) 1.04
Letter: Complement components in cystic fibrosis. Lancet (1973) 1.04
A comparison of the sensitivity of the 1971 and 1982 American Rheumatism Association criteria for the classification of systemic lupus erythematosus. Arthritis Rheum (1984) 1.03
Isoniazid induction of antinuclear antibodies. A prospective study. Ann Intern Med (1978) 1.02
Cell-specific differences in membrane beta-glucosidase from normal and Gaucher cells. Biochim Biophys Acta (1977) 1.01
Observations on cell lines derived from a patient with Hodgkin's disease. Cancer Res (1978) 1.01
Clinical significance of serum properdin levels and properdin deposition in the dermal-epidermal junction in systemic lupus erythematosus. J Clin Invest (1976) 1.00
Improvement of muscle function in acid maltase deficiency by high-protein therapy. Neurology (1983) 1.00
Genetic heterogeneity in acid alpha-glucosidase deficiency. Am J Hum Genet (1983) 1.00
Studies of cellular immunity in Chagas disease: effect of glutaraldehyde-treated specific antigen on inhibition of leukocyte migration. J Immunol (1974) 1.00
Patterns of nuclear fluorescence and DNA-binding activity. Ann Rheum Dis (1973) 0.99
The frequency of chromosome aberrations in tall men with special reference to 47, XYY and 47, XXY. Am J Hum Genet (1976) 0.99
Correlation of anti-Ro antibody with photosensitivity rash in systemic lupus erythematosus patients. Arthritis Rheum (1989) 0.98
Response of lymphocytes to penicillin: comparison with skin tests and circulating antibodies in man. Nature (1967) 0.98
A comparison of the specificity of the 1971 and 1982 American Rheumatism Association criteria for the classification of systemic lupus erythematosus. Arthritis Rheum (1985) 0.97
Genetic and clinical considerations of long-arm deletion of the X chromosome. Pediatrics (1970) 0.97
Duplication of 16q and deletion of 15q. Am J Med Genet (1989) 0.97
Family study of systemic lupus erythematosus: analysis of the clinical history, skin immunofluorescence, and serologic parameters. Arthritis Rheum (1977) 0.95
Confirmation of the assignment of genes of human immunoglobulin heavy chains to chromosome 14 by analysis of Ig synthesis by man-mouse hybridomas. Eur J Immunol (1981) 0.95
Antibodies to native DNA and serum complement (C3) levels. Application to diagnosis and classification of systemic lupus erythematosus. Am J Med (1983) 0.94
Fucosidosis type 2. Pediatrics (1976) 0.94
Further regional localization of the genes for human acid alpha glucosidase (GAA), peptidase D (PEPD), and alpha mannosidase B (MANB) by somatic cell hybridization. Hum Genet (1985) 0.94
An evaluation of the preliminary criteria for the diagnosis of systemic lupus erythematosus. Arthritis Rheum (1973) 0.94
Human-mosquito somatic cell hybrids induced by ultraviolet-inactivated Sendai virus. Nat New Biol (1971) 0.93
Recurrent abortions and chromosome abnormalities. J Obstet Gynaecol Br Commonw (1972) 0.93